Publication | Closed Access

A multicentred phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100mg or 150mg: 1. Contraceptive efficacy and side effects

Contraceptive EfficacyContraceptionHormonal ContraceptiveDepot-medroxyprogesterone AcetateMedicineSide EffectsPharmacotherapyPharmacologyWomen's HealthSide Effect